Home
About
Overview
Sharing Data
ORCID
Help
History (1)
In vivo administration of anti-CD3 prevents malignant progressor tumor growth.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
In vivo administration of anti-CD3 prevents malignant progressor tumor growth.
In vivo administration of anti-CD3 prevents malignant progressor tumor growth. Science. 1988 Oct 28; 242(4878):569-71.
View in:
PubMed
subject areas
Animals
Antigens, Differentiation, T-Lymphocyte
Antigens, Surface
CD3 Complex
Dose-Response Relationship, Immunologic
Immunotherapy
Lymph Nodes
Lymphocyte Activation
Mice
Neoplasm Transplantation
Neoplasms, Experimental
Receptors, Antigen, T-Cell
Receptors, Interleukin-2
Thy-1 Antigens
T-Lymphocytes
authors with profiles
Hans Schreiber